ONT-10

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NameONT-10
Drug Alias NameL-BGLP40ONT-10BGLP-40
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionToll like receptor 4 agonistsMucin-1 modulators
TargetsMucin-1Toll like receptor 4
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCascadian Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCascadian Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksWikipedia